View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
TUESDAY, Feb. 9 (HealthDay News) -- The reduced immune response seen in obese adolescents and adults following hepatitis B virus (HBV) vaccination may be due in part to insufficient needle penetration of muscle, according to research published online Feb. 8 in Pediatrics.
Amy B. Middleman, M.D., of the Baylor College of Medicine in Houston, and colleagues analyzed data from 24 teens and young adults, aged 14 to 24 years. Females weighed more than 90 kg and males more than 120 kg. Subjects were randomized to receive their HBV vaccination series with a 1- or 1.5-inch needle.
The researchers found that subjects vaccinated with a 1.5-inch needle had significantly higher antibody titers to HBV surface antigen compared to the 1-inch-needle group (345.4 versus 189.8 mIU/mL).
"Despite the small sample size, obese adolescents and young adults achieved significantly higher titers of anti-HBs after HBV vaccine when a 1.5-inch needle was used for administration rather than a 1-inch needle. This supports the hypothesis that inadequate muscle penetration is responsible, at least in part, for lower immune response to HBV vaccine among obese adolescent and adult vaccine recipients," the authors write.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top